Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
Neuropsychiatric Disease and Treatment|January 15, 2016
Use of antidepressants in the treatment of major depressive disorder in primary care during a period of economic crisisAntoni Sicras-Mainar, Ruth Navarro-ArtiedaDrug Design, Development and Therapy|June 28, 2014
Use of metformin and vildagliptin for treatment of type 2 diabetes in the elderlyAntoni Sicras-Mainar, Ruth Navarro-ArtiedaGaceta Sanitaria|March 10, 2009
[Validating the Adjusted Clinical Groups [ACG] case-mix system in a Spanish population setting: a multicenter study]Antoni Sicras-Mainar, Ruth Navarro-Artieda, Diabetes Technology & Therapeutics|August 5, 2014
Healthcare costs of the combination of metformin/dipeptidyl peptidase-4 inhibitors compared with metformin/other oral antidiabetes agents in patients with type 2 diabetes and metabolic syndromeAntoni Sicras-Mainar, Ruth Navarro-ArtiedaMedicina Clinica|July 15, 2009
[Cost of arterial hypertension according to levels of morbidity in primary care setting]Antoni Sicras-Mainar, Ruth Navarro-ArtiedaGaceta Sanitaria|October 26, 2010
[Influence of substitution of brand name for generic drugs on therapeutic compliance in hypertension and dyslipidemia]Antoni Sicras Mainar, Ruth Navarro ArtiedaRevista Peruana De Medicina Experimental Y Salud Publica|August 17, 2013
[Adjusted clinicals groups: a patient classification system through risk adjustment]Antonio Sicras-Mainar, Ruth Navarro-ArtiedaRevista Peruana De Medicina Experimental Y Salud Publica|January 20, 2015
[Combination therapy of metformin vs dipeptidulpeptidase inhibitors and sulfonylureas in type 2 diabetes: clinical and economic impact]Antoni Sicras-Mainar, Ruth Navarro-ArtiedaDiabetes & Metabolism Journal|March 3, 2015
Economic impact of combining metformin with dipeptidyl peptidase-4 inhibitors in diabetic patients with renal impairment in spanish patientsAntoni Sicras-Mainar, Ruth Navarro-ArtiedaGaceta Medica De Mexico|March 2, 2016
[Clinical characteristics and treatment response in adult patients with non-Hodgkin's chronic lymphocytic leukemia (CLL)]Antoni Sicras-Mainar, Antonio Castro, Ruth Navarro-ArtiedaPageof 7